NATURAL ESTROGENIC SUBSTANCE-ESTRONE Drug Patent Profile
✉ Email this page to a colleague
When do Natural Estrogenic Substance-estrone patents expire, and when can generic versions of Natural Estrogenic Substance-estrone launch?
Natural Estrogenic Substance-estrone is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in NATURAL ESTROGENIC SUBSTANCE-ESTRONE is estrone. There are nine drug master file entries for this compound. Additional details are available on the estrone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NATURAL ESTROGENIC SUBSTANCE-ESTRONE?
- What are the global sales for NATURAL ESTROGENIC SUBSTANCE-ESTRONE?
- What is Average Wholesale Price for NATURAL ESTROGENIC SUBSTANCE-ESTRONE?
Summary for NATURAL ESTROGENIC SUBSTANCE-ESTRONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 106 |
| Patent Applications: | 3,531 |
| DailyMed Link: | NATURAL ESTROGENIC SUBSTANCE-ESTRONE at DailyMed |
US Patents and Regulatory Information for NATURAL ESTROGENIC SUBSTANCE-ESTRONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | NATURAL ESTROGENIC SUBSTANCE-ESTRONE | estrone | INJECTABLE;INJECTION | 085237-001 | Nov 23, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
